RFK, Jr., Questions Safety of Approved RSV Shots for Babies

Scientific AmericanTuesday, December 9, 2025 at 8:15:00 PM
NeutralScience
  • FDA officials are currently reassessing several approved therapies for treating RSV in infants, despite previous clinical trials indicating these shots were safe. This scrutiny arises amid ongoing public discussions about vaccine safety and efficacy, particularly concerning childhood vaccinations.
  • The implications of this reassessment are significant, as it may affect public confidence in vaccines designed to protect vulnerable infants from RSV, a serious respiratory illness. Any changes in the FDA's stance could influence healthcare practices and parental decisions regarding vaccination.
  • This development reflects broader concerns about vaccine safety and regulatory processes, particularly as the FDA contemplates changes to its vaccine approval protocols. Such changes could impact not only RSV vaccines but also those for other diseases like COVID-19 and influenza, raising questions about accessibility and safety in pediatric healthcare.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended apps based on your readingExplore all apps
Continue Readings
FDA Expands Covid Vaccine Inquiry to Adult Deaths
NegativeScience
The FDA has expanded its inquiry into the Covid vaccine to include adult deaths, claiming a link to 10 children's deaths associated with the vaccine, although it has not provided evidence to substantiate these claims. This development raises significant concerns regarding vaccine safety and public trust in health authorities.